Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The 21st European Hematology Association (EHA) Congress will take place in Copenhagen, Denmark between the 9th and 12th of June 2016. The EHA Annual Congress provides a forum for presenting original unpublished data and sharing ideas for hematological innovation as well as disseminating evidence-based knowledge of primary clinical relevance.

Hematologists and affiliated professionals attending the EHA Congress will be able to: enhance their knowledge of evidence-based approaches on diagnosis and treatment for hematologic diseases; access the latest results on clinical and translational research in hematologic disorders; be updated on emerging innovative techniques, diagnostic tools and risk-assessment strategies in hematology and its subspecialties; communicate, collaborate and network with representatives of a large international audience – medical professionals, national hematology societies, patient groups, medical industry and the media.

EHA 2016

09–12 June 2016 | Bella Center, Copenhagen, Denmark

EHA 2016

09–12 June 2016 | Bella Center, Copenhagen, Denmark

The 21st European Hematology Association (EHA) Congress will take place in Copenhagen, Denmark between the 9th and 12th of June 2016. The EHA Annual Congress provides a forum for presenting original unpublished data and sharing ideas for hematological innovation as well as disseminating evidence-based knowledge of primary clinical relevance.

Hematologists and affiliated professionals attending the EHA Congress will be able to: enhance their knowledge of evidence-based approaches on diagnosis and treatment for hematologic diseases; access the latest results on clinical and translational research in hematologic disorders; be updated on emerging innovative techniques, diagnostic tools and risk-assessment strategies in hematology and its subspecialties; communicate, collaborate and network with representatives of a large international audience – medical professionals, national hematology societies, patient groups, medical industry and the media.